Zdrowie i gospodarka · 14/10/2015
FDA Announces Draft Guidance for Microbial Vectors Used in Gene Therapy
The FDA has released a draft document outlining recommendations for microbial vectors used in gene therapy, aiming to provide clarity for industry sponsors on IND submissions and CMC information for these products.
Source: Federal Register — Food and Drug AdministrationOpen original release →